Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 99.60M | £ 82.30M | £ 119.10M | £ 48.40M | £ 267.00M |
Total Assets | £ 1.34B | £ 1.27B | £ 1.29B | £ 1.18B | £ 1.43B |
Total Debt | £ 327.60M | £ 354.60M | £ 361.80M | £ 380.50M | £ 678.20M |
Net Debt | £ 228.00M | £ 272.30M | £ 242.70M | £ 332.10M | £ 411.20M |
Total Liabilities | £ 873.10M | £ 829.50M | £ 868.30M | £ 814.20M | £ 1.14B |
Stockholders Equity | £ 465.60M | £ 440.60M | £ 423.20M | £ 370.50M | £ 276.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |